Structural determinants of unexpected agonist activity in a retro-peptide analogue of the SDF-1α N-terminus  by Palladino, Pasquale et al.
FEBS 29952 FEBS Letters 579 (2005) 5293–5298Structural determinants of unexpected agonist activity in
a retro-peptide analogue of the SDF-1a N-terminus
Pasquale Palladinoa,*, Barbara Tizzanoa, Carlo Pedonea, Raﬀaele Ragoneb, Filomena Rossia,
Gabriella Savianoc, Teodorico Tancredid, Ettore Benedettia
a Dipartimento delle Scienze Biologiche, C.I.R.Pe.B., Universita` Federico II di Napoli and Istituto di Bioimmagini e Biostrutture, CNR,
Via Mezzocannone 16, 80134 Napoli, Italy
b Dipartimento di Biochimica e Bioﬁsica and CRISCEB, Seconda Universita` di Napoli, Via Costantinopoli 16, 80138 Napoli, Italy
c Dipartimento di Scienze e Tecnologie per lAmbiente e il Territorio, Universita` degli Studi del Molise, Via De Gasperi, 86170 Isernia, Italy
d Istituto di Chimica Biomolecolare, CNR, Via Campi Flegrei 34, 80078 Pozzuoli, Italy
Received 29 April 2005; revised 4 July 2005; accepted 25 July 2005
Available online 12 September 2005
Edited by Christian GriesingerAbstract We have synthesised two retro-peptide analogues of
the stromal cell derived growth factor 1 (SDF-1a) segment
known to be critical for CXCR4 receptor binding, corresponding
to the sequences HSEFFRCPCRFFESH and HSEFFRGGG-
RFFESH. We have assayed the ability of these peptides to acti-
vate extracellular signal-regulated kinase 1/2 phosphorylation in
cells over expressing the SDF-1a receptor, ﬁnding that the ﬁrst
variant was able to serve as an agonist of CXCR4, whereas
the second one was inactive. Finally, by comparing representa-
tive solution structures of the two peptides, we have found that
the biological response of HSEFFRCPCRFFESH may be as-
cribed to a b-b-type turn motif centred on Phe4–Phe5.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The homeostatic CXC chemokine stromal cell derived
growth factor 1 (SDF-1a) is the only known endogenous ago-
nist for CXCR4, a receptor highly expressed in human malig-
nant melanoma, malignant breast tumours and metastases,
also shown to be an HIV-1 co-receptor [1]. Binding and activa-
tion assays indicate that the 29–39 N-terminus fragment near
the transmembrane region of CXCR4 is required for activation
by SDF-1a, whereas the 1–28 amino terminus segment of
CXCR4 is neither necessary nor suﬃcient for activation [2].
As concerns the SDF-1a, the N-terminal lysine (and, possibly,
proline at position 2) residue(s) seems to be required for SDF-
1a activity [3]. The RFFESH sequence, located in the loop re-
gion of SDF-1a at positions 12–17, is necessary for optimal
binding, but not suﬃcient for receptor activation [3]. This se-Abbreviations: CALIBA, calibration of NOE distance constraints;
DYANA, dynamics algorithm for NMR applications; ECL, en-
hanced chemiluminescence; ERK1/2, extracellular signal-regulated
kinases 1/2; MOLMOL, MOLecule analysis and MOLecule display;
SDF-1a, stromal cell derived growth factor 1; TSSA, torsion space
simulated annealing
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doi:10.1016/j.febslet.2005.07.100quence is involved in the initial docking step of a process lead-
ing the N-terminal residues KPVSLSYR at positions 1–8 to
interact with the more buried receptor site. In a model pro-
posed for binding of SDF-1a to CXCR4, dimeric SDF-1a ﬁrst
interacts with endothelial-cell-surface glycosaminoglycans and,
thereafter, with dimeric CXCR4 receptor [4].
On this basis, we have modelled the SDF-1a/CXCR4 inter-
action by the 1–17 N-terminal segment of human SDF-1a
(KPVSLSYR-CPC-RFFESH), SDF-1{1–17}, and the 29–39
fragment of CXCR4 (FREENANFNKI), CXCR4{29–39}
[5], respectively, showing that these peptides bind with a disso-
ciation constant (Kd) in the micromolar range. Aiming to inhi-
bit the chemotactic response of the CXCR4 receptor, we have
used SDF-1{1–17} as a template to further synthesise two N-
terminal analogues of SDF-1a. Namely, we kept the sequence
claimed to be responsible for binding to CXCR4 [3,5],
RFFESH, and replaced the segment supposed to be indispens-
able for receptor activation [3], KPVSLSYR, with the
RFFESH-derived retro-peptide, thus obtaining the analogue
of sequence HSEFFR-CPC-RFFESH, SDF-1{H–H}. More-
over, we substituted the CPC moiety, which makes SDF-1a
a CXC-type chemokine, with three glycines, thus obtaining
the analogue corresponding to the sequence HSEFFR-GGG-
RFFESH, SDF-1{HG3H}. This work reports on the struc-
ture–activity relationships of these peptides.2. Materials and methods
2.1. Peptide synthesis
The N-terminal analogues of SDF-1a, SDF-1{1–17}: KPVSLSYR-
CPCRFFESH, SDF-1{H–H}: HSEFFRCPCRFFESH and SDF-
1{HG3H}: HSEFFRGGGRFFESH, were synthesised by standard
Fmoc solid phase peptide synthesis, puriﬁed by RP-HPLC and charac-
terised by MALDI-TOF mass spectrometry, as described elsewhere [5].
Concerning the CPC sequence in SDF-1{H–H}, we have veriﬁed that
the cysteine thiol groups were in reduced form even after strong oxidis-
ing treatment.
2.2. NMR spectroscopy
Samples were prepared by dissolving the peptide in water (90/10 v/v
H2O/D2O) up to a concentration of 2 mM. The pH was adjusted to 5.0
according to the conditions used in previous studies [6,7]. NMR spec-
tra were acquired at 280 K using a 600 MHz Varian Inova spectrom-
eter or a 500 MHz Bruker DRX spectrometer. 1H–13C spectrum
(HSQC) [8] and 1H TOCSY [9], NOESY [10] and double quantum ﬁl-
tered COSY [11] spectra were used for resonance assignments. NOESYblished by Elsevier B.V. All rights reserved.
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mine NOE build-up rates, which were found to be linear up to
350 ms. 2D-TOCSY experiments were recorded with mixing times of
30 and 70 ms. Sequence speciﬁc assignment was obtained by the com-
bined use of TOCSY and NOESY experiments, according to the
standard procedure [12]. Chemical shift values are reported in Tables 1
and 2.
2.3. Structure calculations
Peak integrals were evaluated by use of NMRView, transferred to
the program package dynamics algorithm for NMR applications
(DYANA) 1.0.6 [13], and converted to upper distance limits by using
the calibration of NOE distance constraints (CALIBA) module of
DYANA. Distance constraints were then worked out by the GRID-
SEARCH module (also implemented in DYANA) to generate a set
of allowed dihedral angles. Structure calculation was carried out with
the macro ANNEAL by torsion angle dynamics. Eighty structures
were calculated by torsion space simulated annealing (TSSA), starting
with a total of 10000 MD steps and a default value of maximum tem-
perature. The twenty best structures in terms of target function were
subjected to cluster analysis by best ﬁtting of backbone atoms of resi-
dues from Glu3 to Asp6 with the program MOLecule analysis and
MOLecule display (MOLMOL) [14].2.4. Western blot analysis
CXCR4 was expressed on human neuroepithelioma CHP100 cells,
according to a previously reported procedure [15,16]. Blots were incu-
bated for 1 h with 5% non-fat dry milk or 3% bovine serum albumin to
block non-speciﬁc binding sites and then incubated with speciﬁc anti-
bodies. The immunoreactivity was detected with a enhanced chemilu-Table 1
1H chemical shift values for the peptide SDF-1{H–H}
AA NH aCH bCH
His1 4.10 3.15
Ser2 8.71 4.24 3.59
Glu3 8.56 4.06 1.58/1.66
Phe4 8.16 4.35 2.69/2.80
Phe5 7.97 4.26 2.7
Arg6 8.02 3.95 1.40/1.48
Cys7 8.21 4.39 2.63/2.63
Pro8 4.16 1.67/2.04
Cys9 8.25 4.14 2.61/2.61
Arg10 8.24 3.99 1.39/1.39
Phe11 7.99 4.2 2.7
Phe12 7.9 4.29 2.7
Glu13 8.01 4.05 1.65/1.77
Ser14 8.15 4.11 3.59
His15 7.98 4.27 2.87/3.02
Table 2
1H chemical shift values of the peptide SDF-1{HG3H}
AA NH aCH bCH
His1 4.08 3.11
Ser2 8.68 4.23 3.55/3.55
Glu3 8.47 4.07 1.60/1.65
Phe4 8.11 4.36 2.64/2.75
Phe5 8.04 4.30 2.71
Arg6 8.02 3.92 1.26/1.26
Gly7 7.65 3.61/3.61
Gly8 8.10 3.66/3.66
Gly9 8.10 3.64/3.64
Arg10 7.93 3.93 1.32/1.32
Phe11 8.02 4.28 2.62/2.74
Phe12 7.89 4.25 2.75/2.66
Glu13 7.95 4.04 1.61/1.74
Ser14 8.09 4.07 3.55/3.55
His15 7.99 4.28 2.84/3.00minescent substrate (ECL). Relative band intensity was evaluated by
densitometry (Scan Jet 4c HP) and software analysis (Jandel, Sigma
Gel).3. Results
3.1. Sequential assignment and secondary structures
The TOCSY spectra show well resolved resonances for al-
most all residues. However, some overlap is observed for the
peptide SDF-1{H–H} which exhibits identical b and aromatic
protons chemical shifts for residues Phe5, Phe11 and Phe12. The
chemical shifts corresponding to the backbone amidic and al-
pha protons for these residues are, on the other hand, not
degenerate (see Table 1), allowing the unambiguous use of
the related NOEs in structural calculations. The Cys7–Pro8
peptide bond was found in trans conﬁguration, as indicated
by the small diﬀerence (ca. 5 ppm) of the 13C chemical shifts
between b- and c-carbon atoms of the proline residue.
3JNH–CH coupling constant values are in the range of multi-
ple / angle values for both peptides, and therefore are not in-
cluded in structure calculations. Temperature coeﬃcient
analysis of NHs for both peptides indicates that all amide pro-
tons are exposed to solvent, in accordance with previous ﬁnd-
ings [6]. NOESY spectra show strong daN(i,i+1) and weak
dNN(i,i+1) sequential eﬀects for both peptides (see Fig. 1). AscCH dCH Other
4H 7.14/2H 8.36
1.93/2.00
2,6H 6.9
2,6H 6.9
1.27 2.91 eNH 6.98
1.78/1.78 3.53/3.55
1.18/1.18 2.87 eNH 6.92
2,6H 6.9
2,6H 6.9
2.1/2.1
4H 6.99/2H 8.28
cCH dCH Other
4H 7.13/2H 8.33
1.97/1.97
2,6H 6.89
2,6H 7.0/3,5H 6.9
1.38/1.51 2.85/2.85 eNH 6.92
1.11/1.11 2.80 eNH 6.85
2,6H 6.87/3,5H 7.02
2,6H 6.90
2.1/2.1
4H 6.97/2H 8.27
Fig. 1. Regions of 350-ms NOESY spectra. Panels A1/A2 (SDF-1{H–H}) and B1/B2 (SDF-1{HG3H}) show the daN[i,i + 1] and dNN[i,i + 1]
connectivities.
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Phe 5, 11 and 12 of peptide SDF-1{H–H} does not allow the
unambiguous assignment of the NOE eﬀects involving the side
chain protons of these residues, and therefore they have not
been included in the structural analysis. However, we have
avoided problems arising from the massive overlap of signals
by aligning peptides on the basis of their sequence identities
and assigning HN–HN(i,i+1) NOEs according to the pattern
previously found for SDF-1{1–17} [6], in which residues at
positions 5–8 form a b-aR type turn:SDF-1{1–17} KPVSLSYR-CPC-RFFESHSDF-1{H–H} HSEFFR-CPC-RFFESHSDF-1{HG3H} HSEFFR-GGG-RFFESHSequential and medium range NOEs for peptides SDF-1{H–
H} and SDF-1{HG3H} are summarised in Fig. 2A and B.
From a preliminary analysis of all spectral parameters, the
presence of both extended and folded regions of the backbone
for both peptides was hypothesised. Observation of fairly
strong daN(i,i+1) eﬀects indicates the prevailing presence of ex-tended structures, in agreement with the behaviour of chemical
shifts, temperature coeﬃcients and coupling constants. The
presence of dNN(i,i+1) eﬀects, however, shows that a folded
structure (or a family of such structures) is also present and
makes it possible to interpret the observed backbone NOEs
for both SDF-1{H–H} and SDF-1{HG3H} on the basis of a
mixture of folded and extended conformers.
In analogy with previous work on SDF-1{1–17} [6], the dNN
eﬀect between Phe4 and Phe5 in SDF-1{H–H} suggests the
presence of a turn involving residues Glu3, Phe4, Phe5 and
Arg6, with the two aromatic residues occupying the positions
2 and 3. However, it is not possible to classify deﬁnitely this
turn as the b-aR type featured by SDF-1{1–17} [6], because
the presence of a daN (2ﬁ 4) eﬀect between Phe4 and Arg6 is
ambiguous, due to overlapped resonances. dNN connectivities
are also observed between Glu3 and Phe4 as well as Arg6 and
Cys7, suggesting a partial fold of the amino terminal part of
the peptide. Moreover, even in our case, there is evidence of
a second local structure involving the small sequence Arg10–
Phe11. This structure may not be univocal, since it is based
on a limited number of interatomic distances of the N-terminal
residues of the sequence, but it is possible to test the validity by
Fig. 3. Stereo view of the backbone clustering analysis for the region
3–6 of SDF-1{H–H} and SDF-1{HG3H}. The mean structure of
residues 2–7 from the major conformational subfamilies is indicated in
bold for SDF-1{H–H} (top, blue) and SDF-1{HG3H} (bottom,
green).
Fig. 2. Sequential and medium range NOE connectivities. Connectiv-
ities were derived from NOESY spectra at 350 ms mixing time for
SDF-1{H–H} and SDF-1{HG3H} (panels A and B, respectively).
Backbone NOE connectivities are indicated by horizontal lines
between residues, with thickness indicating their relative magnitude.
The ﬁrst three lines below the amino acid sequence represent torsion
angle restraints for the backbone torsion angles / and w, and for the
side-chain torsion angle v1. For / and w, a m symbol indicates
compatibility with an ideal a-helix or 310-helix; a . symbol indicates
compatibility with an ideal parallel or antiparallel b-strand; a w
symbol encloses conformation of both a and b secondary structure
types; and ad symbol marks a restraint that excludes the torsion angle
values of these regular secondary structure elements. Torsion angle
restraints for v1 are depicted by ﬁlled squares of three diﬀerent
decreasing sizes, depending on whether they allow for one, two or all
three of the staggered rotamer positions.
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consistency with biological activity.
3.2. Structure calculations and analysis
A total of 118 observed NOEs were used for structure calcu-
lations of SDF-1{H–H}. Distance restraints derived from
intra-residue, sequential and medium range NOEs were intro-
duced in SA torsion space calculation performed by DYANA
package. The best twenty structures in terms of RMSD were
selected from 80 structures sampled in TSSA calculations.
An analogous procedure has been employed for calculations
on SDF-1{HG3H}.
Backbone clustering analysis for SDF-1{H–H} in the region
3–6 led to the identiﬁcation of four structural families. The
most populated one contains 13 structures with a backbone
RMSD of 0.36 ± 0.14 A˚ for residues 3–6. Fig. 3 (top) illus-
trates, from residue 2 to 7, the bundle of conformers pertaining
to the major subfamily of the SDF-1{H–H} peptide, with the
best ﬁtting of the sequence segment 3–6. A comparison
between the canonical angles for a b-aR type turn with the an-
gles of a representative structure for peptide SDF-1{H–H}
shows a close similarity for all angles except for w of Phe5,
which suggests a b-b type turn (Table 3) [17]. The same cluster
analysis was carried out for SDF-1{HG3H}, leading to the
identiﬁcation of ﬁve structural families. Fig. 3 (bottom) shows
the representative structure of the most populated family of
SDF-1{HG3H} for residues 2–7. Even in this case, the back-
bone best ﬁtting was performed on the segment 3–6 (Table 4).3.3. Biological assays
Fig. 5 shows that an increased phosphorylation of extracel-
lular signal-regulated kinases 1/2 (ERK1/2) occurred on stim-
ulation of CHP100 cells with 125 nM SDF-1a (440 ± 26% of
control values after 30 min). When cells were stimulated with
either SDF-1{1–17} or SDF-1{H–H} for the same period,
ERK1/2 phosphorylation was activated in a dose-dependent
manner, reaching its maximal value at 250 nM for both com-
pounds (190 ± 23% and 140 ± 13%, respectively; mean of three
diﬀerent experiments ± S.E.). Instead, the SDF-1{HG3H} pep-
tide was inactive.4. Discussion
According to previous data [8,11], we have previously eval-
uated the aﬃnity of the SDF-1a-based heptadecapeptide
SDF-1{1–17} for the CXCR4-derived peptide CXCR4{29–
39} [5]. We have then used SDF-1{1–17} as a template to
synthesise two novel N-terminal analogues of SDF-1a, the
pentadecapeptides SDF-1{H–H} and SDF-1{HG3H}, both
retaining the receptor binding motif RFFESH and lacking
the N-terminal KPVSLSYR segment, which was substituted
with the RFFESH-derived retro-peptide. Furthermore, in the
SDF-1{HG3H} sequence, the central CPC segment of SDF-
1{H–H} was replaced by three glycines. By ﬂuorimetric titra-
tions (not shown), we have estimated that even these newly
synthesised peptides bind to CXCR4{29–39}, as expected,
with dissociation constants in the same micromolar range as
that measured for SDF-1{1–17} [5]. Nevertheless, the solution
structures of SDF-1{H–H} and SDF-1{HG3H} at 280 K and
pH 5.0, as determined by NMR spectroscopy and DYANA
structure calculations, are quite diﬀerent. A comparison be-
tween the N-terminal fragments including the residues at posi-
tions 2–7 underlines diﬀerences in both the structural fold of
the backbone and the spatial disposition of side chains. Fur-
thermore, SDF-1{H–H} does not show any antagonist activity
toward the CXCR4 receptor, but behaves as an agonist, like
SDF-1{1–17}, whereas SDF-1{HG3H} is completely inactive.
Table 3
Angles and order parameters for the peptide SDF-1{H–H}a
Residue / /S w wS v1 v1S
Ser2 131.1 ± 35.0 0.836 138.1 ± 71.7 0.561
Glu3 129.2 ± 102.0 0.359 79.7 ± 15.9 0.965 47.5 ± 76.7 0.386
Phe4 111.9 ± 31.8 0.863 60.5 ± 20.1 0.944 131.8 ± 10.3 0.985
Phe5 152.4 ± 22.2 0.933 161.7 ± 51.6 0.701 52.3 ± 15.1 0.968
Arg6 106.0 ± 74.0 0.555 83.0 ± 3.7 0.998 41.9 ± 60.6 0.574
Cys7 113.4 ± 74.6 0.536 132.0 ± 72.0 0.653
a/, w, v1 and S values for residues 2–7, as computed from the structures of the major family identiﬁed by clustering residues 3–6.
Table 4
Angles and order parameters for the peptide SDF-1{HG3H}
a
Residue / /S w wS v1 v1S
Ser2 117.4 ± 21.4 0.941 150.4 ± 106.6 0.123
Glu3 124.0 ± 29.6 0.893 54.1 ± 38.1 0.827 99.6 ± 30.4 0.8
Phe4 24.2 ± 44.0 0.769 84.8 ± 13.8 0.975 44.6 ± 59.6 0.621
Phe5 87.2 ± 2.7 0.999 149.6 ± 4.8 0.997 46.8 ± 1.1 1.000
Arg6 64.1 ± 0.1 1.000 67.9 ± 0.0 1.000 60.5 ± 0.1 1.000
Gly7 99.6 ± 111.4 0.183
a/, w, v1 and S values for residues 2–7, as computed from the structures of the major family identiﬁed by clustering residues 3–6.
Fig. 4. Backbone superposition of SDF-1{H–H} and N-terminal
region of SDF-1a. The solution structure (NMR, blue) of SDF-1{H–
H} (residues 2–7) and the solid-state structure (X-ray, yellow) of the
corresponding N-terminal region of SDF-1a (residues 4–9) are
compared. The superposition is the best ﬁtting of the region compris-
ing residues 2–7.
Fig. 5. Western blot analysis of ERK1/2 phosphorylation in human
CHP100 neuroepithelioma cells. (A) SDF-1{1–17} (lanes 2–4); (B)
SDF-1{H–H} (lanes 5–7); (C) SDF-1a (lane 8). Upper panel: anti
phospho-ERK1/2. Lower panel: anti ERK2 as a control for equal
protein loading.
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determining the allowed conformer populations we have iden-
tiﬁed conformational diﬀerences responsible for the antipodal
biological response. The assignment of HN–HN(i,i+1) connec-
tivities according to those previously found for SDF-1{1–17}
[6] entails that the SDF-1{H–H} structure displays a motif
similar to a turn not stabilised by H-bonding and centred on
the Phe4–Phe5 tract, closely resembling the N-terminal 4–9
fragment in the SDF-1a crystal structure (Fig. 4) [18].
Finally, it is worth noting that the biological behaviour of
SDF-1{H–H} contrasts the view that wild-type Lys1 and
Pro2 are necessary for determining the agonist activity of
SDF-1a related peptides [3], but the recent identiﬁcation oftwo novel agonists of the CXCR4 receptor [19], with a non-na-
tive 1–4 sequence in the N-terminal region, agrees with our
conclusion. Nevertheless, the manner how the insertion of a
bioactive peptide may aﬀect the behaviour of the full-length
chemokine is not plainly predictable. In conclusion, there is
evidence that non-native sequences may be well involved in
recognizing as well as activating the CXCR4 receptor, but
comprehension of structural features underlying the chemo-
kine biological response still needs in-depth studies (see Fig. 5).
References
[1] Feng, Y., Broder, C.C., Kennedy, P.E. and Berger, E.A. (1996)
HIV-1 entry cofactor: functional cDNA cloning of a seven-
transmembrane, G protein-coupled receptor. Science 272, 872–
877.
[2] Doranz, B.J., Orsini, M.J., Turner, J.D., Hoﬀman, T.L., Berson,
J.F., Hoxie, J.A., Peiper, S.C., Brass, L.F. and Doms, R.W.
(1999) Identiﬁcation of CXCR4 domains that support coreceptor
and chemokine receptor functions. J. Virol. 73, 2752–2761.
[3] Crump, M.P., Gong, J.H., Loetscher, P., Rajarathnam, K.,
Amara, A., Arenzana-Seisdedos, F., Virelizier, J.L., Baggiolini,
M., Sykes, B.D. and Clark-Lewis, I. (1997) Solution structure and
basis for functional activity of stromal cell-derived factor-1;
dissociation of CXCR4 activation from binding and inhibition of
HIV-1. EMBO J. 16, 6996–7007.
5298 P. Palladino et al. / FEBS Letters 579 (2005) 5293–5298[4] Babcock, G.J., Farzan, M. and Sodroski, J. (2003) Ligand-
independent dimerization of CXCR4, a principal HIV-1 corecep-
tor. J. Biol. Chem. 278, 3378–3385.
[5] Palladino, P., Pedone, C., Ragone, R., Rossi, F., Saviano, M. and
Benedetti, E. (2003) A simpliﬁed model of the binding interaction
between stromal cell-derived factor-1 chemokine and CXC
chemokine receptor 4. Protein Pept. Lett. 10, 133–138.
[6] Elisseeva, E.L., Slupsky, C.M., Crump, M.P., Clark-Lewis, I. and
Sykes, B.D. (2000) NMR studies of active N-terminal peptides of
stromal cell-derived factor-1. Structural basis for receptor bind-
ing. J. Biol. Chem. 275, 26799–26805.
[7] Booth, V., Slupsky, C.M., Clark-Lewis, I. and Sykes, B.D. (2003)
Unmasking ligand binding motifs: identiﬁcation of a chemokine
receptor motif by NMR studies of antagonist peptides. J. Mol.
Biol. 327, 329–334.
[8] Dorman, D.E. and Bovey, F.A. (1973) Carbon-13 magnetic
resonance spectroscopy. The spectrum of proline in oligopeptides.
J. Org. Chem. 38, 2379–2383.
[9] Bax, A. and Davis, D.G. (1985) MLEV-17-based two-dimen-
sional homonuclear magnetization transfer spectroscopy. J.
Magn. Res. 65, 355–360.
[10] Jeener, J., Meyer, B.H., Bachman, P. and Ernst, R.R. (1979)
Investigation of exchange processes by two-dimensional NMR
spectroscopy. J. Chem. Phys. 71, 4546–4553.
[11] Rance, M., So¨rensen, O.W., Bodenhausen, G., Wagner, G., Ernst,
R.R. and Wu¨thrich, K. (1983) Improved spectral resolution in
COSY 1H NMR spectra of proteins via double quantum ﬁltering.
Biochem. Biophys. Res. Commun. 117, 479–485.[12] Wu¨thrich, K. (1986) NMR of Proteins and Nucleic Acids, Wiley,
New York.
[13] Gu¨ntert, P., Mumenthaler, C. and Wu¨thrich, K. (1997) Torsion
angle dynamics for NMR structure calculation with the new
program DYANA. J. Mol. Biol. 273, 283–298.
[14] Koradi, R., Billeter, M. and Wu¨thrich, K. (1996) MOLMOL: a
program for display and analysis of macromolecular structures. J.
Mol. Graph. 14, 51–55.
[15] Catani, M.V., Corasaniti, M.T., Navarra, M., Nistico`, G.,
Finazzi-Agro`, A. and Melino, G. (2000) gp120 induces cell death
in human neuroblastoma cells through the CXCR4 and CCR5
chemokine receptors. J. Neurochem. 74, 2373–2379.
[16] Floridi, F., Trettel, F., Di Bartolomeo, S., Ciotti, M.T. and
Limatola, C. (2003) Signalling pathways involved in the chemo-
tactic activity of CXCL12 in cultured rat cerebellar neurons and
CHP100 neuroepithelioma cells. J. Neuroimmunol. 135, 38–46.
[17] Wilmot, C.M. and Thornton, J.M. (1990) Beta-turns and their
distortions: a proposed new nomenclature. Protein Eng. 3, 479–
493.
[18] Dealwis, C., Fernandez, E.J., Thompson, D.A., Simon, R.J.,
Siani, M.A. and Lolis, E. (1998) Crystal structure of chemically
synthesized [N33A] stromal cell-derived factor 1 alpha, a potent
ligand for the HIV-1 fusin coreceptor. Proc. Natl. Acad. Sci. USA
95, 6941–6946.
[19] Sachpatzidis, A., Benton, B.K., Manfredi, J.P., Wang, H.,
Hamilton, A., Dohlman, H.G. and Lolis, E. (2003) Identiﬁcation
of allosteric peptide agonists of CXCR4. J. Biol. Chem. 278, 896–
907.
